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No endocytosis in the axonal entry
 
t takes two steps to localize a sodium channel to its 
proper location at the entrance to the axon, based on 
results on page 571 from Fache et al. Their findings are 
consistent with a targeting system involving both tethering 
and selective elimination.
The boundary between the neuronal cell body and the 
axon, called the axonal initial segment (AIS), is a dense net-
work of actin and ankyrin G and 
 
 
 
 IV spectrin, where clusters 
of sodium channels initiate action potentials. A cytoplasmic 
loop from the Na
 
v
 
1.2 sodium channel binds to ankyrin and, 
when added to non-AIS proteins, can direct them to this 
segment. The authors now show that this loop contains two 
separate domains essential for precise localization.
One domain tethers the protein to ankyrin, and the other 
removes it from surface of the rest of the neuron. Mutation 
of the first domain—a 27-residue stretch that binds to 
ankyrin—caused chimeric proteins with the mutant loop 
to localize throughout the cell.
A nearby but nonoverlapping domain was also needed 
to limit protein localization to the AIS by removing proteins 
I
AIS proteins (green) are internalized everywhere except the AIS.
 
from the surface elsewhere. Newly made chimeric proteins were sent to the plasma membrane all around the cell body, 
including the AIS. Those that did not land at or move to the AIS were then internalized, as were proteins that somehow found 
their way to the far end of the axon. Removal of 19 residues in the NH
 
2
 
-terminal portion of the loop abolished this 
endocytosis, and protein accumulated throughout the neuron.
It is not clear what prevents the endocytosis in the AIS, although linkage to ankyrin does not seem to be necessary. Perhaps 
endocytosis is generally limited in the AIS. The NH
 
2
 
-terminal portion of the loop is unlike any known internalization 
sequence and should provide a good starting point to identify proteins needed for this endocytic pathway. 
 
 
 
Antagonizing T cells
 
n page 579, Sumen et al. show 
that some mutant variants of antigens 
disable T cells by preventing the clustering 
of MHC molecules at the interface between 
T cells and antigen-presenting cells (APCs). 
The results also suggest that integrins are 
not the entire answer to getting T cells to 
stop at their targets.
Certain antigen variants, called antag-
onists, interfere with a T cell’s ability to 
respond to otherwise stimulatory antigens. 
Although they are often effective only at 
high concentrations, antagonists may be 
used—either by pathogens or as thera-
pies against autoimmune diseases—to 
thwart strong defense responses. But 
just how they get in the way is unclear. 
In the new work, the authors show ways 
in which antagonists hinder the forma-
tion of the immunological synapse—the 
junction between the T cell and the APC 
that contains peptide-MHC molecules, 
O
 
T cell receptors (TCRs), and 
adhesion proteins.
Synapses that formed on 
membranes containing excess 
antagonists were sparse in MHC 
clusters. Fewer MHCs means less 
T cell proliferation and cytokine 
production, probably because 
fewer TCRs are engaged. Even 
long after antagonist was re-
moved, the T cells still did not 
respond when exposed to active 
antigens. In their half-active state, 
T cells migrated past their anti-
genic targets rather than making 
the normal full stop.
This crippling of T cell adhesion appears 
to result from a failure to focus adhesion 
rather than a failure in integrin activation 
itself. The ICAM-1 adhesion molecule, 
which is a measure of active integrins, was 
equally dense in synapses with or without 
antagonists. With antagonists, ICAM-1 
accumulated in a crescent shape, not the 
tight circular pattern characteristic of a 
strong synapse. ICAM-1 is probably 
pushed into this odd pattern by the 
continued cell movement.
 
 
 
 
ICAM-1 forms a sickle-like shape on T cells in the 
presence of antagonists.
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